BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36028327)

  • 1. Perception of Fragmented Letters by Patients With Pathologically Confirmed Dementia With Lewy Bodies or Alzheimer Disease.
    Salmon DP; Smirnov DS; Coughlin DG; Hamilton JM; Landy KM; Filoteo JV; Hiniker A; Hansen LA; Galasko D
    Neurology; 2022 Nov; 99(18):e2034-e2043. PubMed ID: 36028327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders.
    Coughlin D; Xie SX; Liang M; Williams A; Peterson C; Weintraub D; McMillan CT; Wolk DA; Akhtar RS; Hurtig HI; Branch Coslett H; Hamilton RH; Siderowf AD; Duda JE; Rascovsky K; Lee EB; Lee VM; Grossman M; Trojanowski JQ; Irwin DJ
    Ann Neurol; 2019 Feb; 85(2):259-271. PubMed ID: 30549331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF tau and β-amyloid predict cerebral synucleinopathy in autopsied Lewy body disorders.
    Irwin DJ; Xie SX; Coughlin D; Nevler N; Akhtar RS; McMillan CT; Lee EB; Wolk DA; Weintraub D; Chen-Plotkin A; Duda JE; Spindler M; Siderowf A; Hurtig HI; Shaw LM; Grossman M; Trojanowski JQ
    Neurology; 2018 Mar; 90(12):e1038-e1046. PubMed ID: 29467305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum.
    Sierra M; Gelpi E; Martí MJ; Compta Y
    Neuropathol Appl Neurobiol; 2016 Aug; 42(5):451-62. PubMed ID: 26810462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathology and temporal onset of visual hallucinations, misperceptions and family misidentification distinguishes dementia with Lewy bodies from Alzheimer's disease.
    Ferman TJ; Arvanitakis Z; Fujishiro H; Duara R; Parfitt F; Purdy M; Waters C; Barker W; Graff-Radford NR; Dickson DW
    Parkinsonism Relat Disord; 2013 Feb; 19(2):227-31. PubMed ID: 23182311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy.
    Uchikado H; Lin WL; DeLucia MW; Dickson DW
    J Neuropathol Exp Neurol; 2006 Jul; 65(7):685-97. PubMed ID: 16825955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tau pathology associates with in vivo cortical thinning in Lewy body disorders.
    Spotorno N; Coughlin DG; Olm CA; Wolk D; Vaishnavi SN; Shaw LM; Dahodwala N; Morley JF; Duda JE; Deik AF; Spindler MA; Chen-Plotkin A; Lee EB; Trojanowski JQ; McMillan CT; Weintraub D; Grossman M; Irwin DJ
    Ann Clin Transl Neurol; 2020 Dec; 7(12):2342-2355. PubMed ID: 33108692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive Profile and Markers of Alzheimer Disease-Type Pathology in Patients With Lewy Body Dementias.
    Howard E; Irwin DJ; Rascovsky K; Nevler N; Shellikeri S; Tropea TF; Spindler M; Deik A; Chen-Plotkin A; Siderowf A; Dahodwala N; Weintraub D; Shaw LM; Trojanowski JQ; Vaishnavi SN; Wolk DA; Mechanic-Hamilton D; Morley JF; Duda JE; Grossman M; Cousins KAQ
    Neurology; 2021 Apr; 96(14):e1855-e1864. PubMed ID: 33593865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α-Synuclein Heteromers in Red Blood Cells of Alzheimer's Disease and Lewy Body Dementia Patients.
    Daniele S; Baldacci F; Piccarducci R; Palermo G; Giampietri L; Manca ML; Pietrobono D; Frosini D; Nicoletti V; Tognoni G; Giorgi FS; Lo Gerfo A; Petrozzi L; Cavallini C; Franzoni F; Ceravolo R; Siciliano G; Trincavelli ML; Martini C; Bonuccelli U
    J Alzheimers Dis; 2021; 80(2):885-893. PubMed ID: 33579836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease.
    Barba L; Abu-Rumeileh S; Halbgebauer S; Bellomo G; Paolini Paoletti F; Gaetani L; Oeckl P; Steinacker P; Massa F; Parnetti L; Otto M
    Neurology; 2023 Jul; 101(1):e50-e62. PubMed ID: 37188538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural speech markers of Alzheimer's disease co-pathology in Lewy body dementias.
    Shellikeri S; Cho S; Cousins KAQ; Liberman M; Howard E; Balganorth Y; Weintraub D; Spindler M; Deik A; Lee EB; Trojanowski JQ; Irwin D; Wolk D; Grossman M; Nevler N
    Parkinsonism Relat Disord; 2022 Sep; 102():94-100. PubMed ID: 35985146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual Perceptual Organization Ability in Autopsy-Verified Dementia with Lewy Bodies and Alzheimer's Disease.
    Mitolo M; Hamilton JM; Landy KM; Hansen LA; Galasko D; Pazzaglia F; Salmon DP
    J Int Neuropsychol Soc; 2016 Jul; 22(6):609-19. PubMed ID: 27221597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Transforming Growth Factor β2 in the Neocortex of Alzheimer's Disease and Dementia with Lewy Bodies is Correlated with Disease Severity and Soluble Aβ42 Load.
    Chong JR; Chai YL; Lee JH; Howlett D; Attems J; Ballard CG; Aarsland D; Francis PT; Chen CP; Lai MK
    J Alzheimers Dis; 2017; 56(1):157-166. PubMed ID: 27911312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hippocampal subfield pathologic burden in Lewy body diseases vs. Alzheimer's disease.
    Coughlin DG; Ittyerah R; Peterson C; Phillips JS; Miller S; Rascovsky K; Weintraub D; Siderowf AD; Duda JE; Hurtig HI; Wolk DA; McMillan CT; Yushkevich PA; Grossman M; Lee EB; Trojanowski JQ; Irwin DJ
    Neuropathol Appl Neurobiol; 2020 Dec; 46(7):707-721. PubMed ID: 32892355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology.
    Tsuang D; Leverenz JB; Lopez OL; Hamilton RL; Bennett DA; Schneider JA; Buchman AS; Larson EB; Crane PK; Kaye JA; Kramer P; Woltjer R; Kukull W; Nelson PT; Jicha GA; Neltner JH; Galasko D; Masliah E; Trojanowski JQ; Schellenberg GD; Yearout D; Huston H; Fritts-Penniman A; Mata IF; Wan JY; Edwards KL; Montine TJ; Zabetian CP
    Neurology; 2012 Nov; 79(19):1944-50. PubMed ID: 23035075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Faster cognitive decline in dementia due to Alzheimer disease with clinically undiagnosed Lewy body disease.
    Malek-Ahmadi M; Beach TG; Zamrini E; Adler CH; Sabbagh MN; Shill HA; Jacobson SA; Belden CM; Caselli RJ; Woodruff BK; Rapscak SZ; Ahern GL; Shi J; Caviness JN; Driver-Dunckley E; Mehta SH; Shprecher DR; Spann BM; Tariot P; Davis KJ; Long KE; Nicholson LR; Intorcia A; Glass MJ; Walker JE; Callan M; Curry J; Cutler B; Oliver J; Arce R; Walker DG; Lue LF; Serrano GE; Sue LI; Chen K; Reiman EM
    PLoS One; 2019; 14(6):e0217566. PubMed ID: 31237877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lewy body variant of Alzheimer's disease or cerebral type lewy body disease? Two autopsy cases of presenile onset with minimal involvement of the brainstem.
    Yokota O; Tsuchiya K; Uchihara T; Ujike H; Terada S; Takahashi M; Kimura Y; Ishizu H; Akiyama H; Kuroda S
    Neuropathology; 2007 Feb; 27(1):21-35. PubMed ID: 17319280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive and structural magnetic resonance imaging features of Lewy body dementia and Alzheimer's disease.
    Rodriguez MJ; Potter E; Shen Q; Barker W; Greig-Custo M; Agron J; Loewenstein D; Duara R
    Alzheimers Dement; 2012 May; 8(3):211-8. PubMed ID: 22546353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences for clinical correlates of substantia nigra neuron loss in people with Lewy body pathology.
    Bayram E; Coughlin DG; Rajmohan R; Litvan I
    Biol Sex Differ; 2024 Jan; 15(1):8. PubMed ID: 38243325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantifying regional α -synuclein, amyloid β, and tau accumulation in lewy body dementia.
    Miller RL; Dhavale DD; O'Shea JY; Andruska KM; Liu J; Franklin EE; Buddhala C; Loftin SK; Cirrito JR; Perrin RJ; Cairns NJ; Campbell MC; Perlmutter JS; Kotzbauer PT
    Ann Clin Transl Neurol; 2022 Feb; 9(2):106-121. PubMed ID: 35060360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.